phosphoramidic acid has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraniak, J; Cieslak, M; Kaczmarek, R; Krakowiak, A; Krolewska, K; Kulik, K; Nawrot, B; Pietkiewicz, A; Radzikowska, E | 1 |
| Beauregard, J; Collins, L; Dostie, S; Guindon, Y; Labbé, MO; Lefebvre, CA; Maharsy, W; Nemer, M; Prévost, M | 1 |
2 other study(ies) available for phosphoramidic acid and gemcitabine
| Article | Year |
|---|---|
N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs.
Topics: Amides; Deoxycytidine; DNA Polymerase I; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; Gemcitabine; HeLa Cells; Humans; K562 Cells; Molecular Structure; Phosphoric Acids; Prodrugs; Structure-Activity Relationship | 2014 |
Identification of a C3'-nitrile nucleoside analogue inhibitor of pancreatic cancer cell line growth.
Topics: Amides; Antineoplastic Agents; Apoptosis; Benzylamines; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gemcitabine; Glycosylation; Humans; Mutation; Nitriles; Pancreatic Neoplasms; Phosphoric Acids; Proto-Oncogene Proteins p21(ras); Purines; Structure-Activity Relationship | 2020 |